Group 1 - The controlling shareholder of Guanzhong Ecological plans to change to Deep Blue Financial Whale, with resumption of trading on September 29 [1] - Zengsheng Technology's controlling shareholder intends to reduce its stake by no more than 3% [1] - Fengyuzhu's shareholder plans to reduce its stake by no more than 3% [1] - Zhonghuan Environmental Protection is planning a change of control and has suspended trading [1] - Nanjing Pharmaceutical's subsidiary, Guangyao Phase II Fund, is acquiring 11.04% of the company's shares [1] - Hailianxun has received approval from the CSRC for a stock swap merger with Hangqilun [1] Group 2 - Jinggong Convertible Bond and Kangyi Convertible Bond will not undergo adjustments [2] - Various convertible bonds are listed with their current prices, redemption prices, last trading days, last conversion days, conversion values, remaining scales, and the proportion of convertible bonds to the underlying stocks [4][6]

证券代码：300869 证券简称：康泰医学 公告编号：2025-045 债券代码：123151 债券简称：康医转债 康泰医学系统（秦皇岛）股份有限公司 关于"康医转债"转股价格调整的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 一、可转换公司债券基本情况 经中国证券监督管理委员会《关于同意康泰医学系统（秦皇岛）股份有限公 司向不特定对象发行可转换公司债券注册的批复》（证监许可〔2022〕960 号）同 意注册，康泰医学系统（秦皇岛）股份有限公司（以下简称"公司"或"康泰医 学"）向不特定对象发行 7,000,000 张可转换公司债券，每张面值为 100 元，募集 资金总额人民币 700,000,000.00 元。经深圳证券交易所（以下简称"深交所"）同 意，公司本次可转换公司债券于 2022 年 7 月 20 日起在深交所挂牌交易，债券简 称"康医转债"，债券代码"123151"，初始转股价格为 28.22 元/股。 二、"康医转债"转股价格调整的相关规定 《康泰医学系统（秦皇岛）股份有限公司创业板向不特定对象发行可转换公 司债券募集说明书 ...

Group 1 - The core viewpoint of the article discusses various corporate actions related to convertible bonds and stock control changes, indicating a dynamic environment in the investment landscape [1] Group 2 - Haoke Convertible Bond is approaching a down adjustment [1] - Xizi Clean Energy's subsidiary plans to sign a relocation compensation agreement worth 274 million yuan [1] - Kesu Convertible Bond is subject to strong redemption [1] - Xuelong Biological's controlling shareholder is planning a change in company control, leading to a stock suspension [1] - Kangyi Convertible Bond will not undergo a down adjustment [1]